#64 Most Valued WorldwideAMGN • NASDAQHealthcareRead on GrokipediaWWikipediaLive Market Capitalization
Amgen Inc.
Headquartered in Thousand Oaks, California, USA • Led by CEO Robert A. Bradway
Enterprise Market Capitalization
$175.0 Billion
+0.46% (+$0.8B 24h)
Share Price: $320.00 USD
Share Price
$320.00
AMGN
P/E Ratio
42.1x
Price to Earnings
Annual Revenue
$28.2B
TTM Revenue
Founded
1980
46 Years Active
Employees
26,700
Global Workforce
Exchange
NASDAQ
United States
Corporate Overview
Amgen is one of the world's biotechnology pioneers, developing therapeutics for cardiovascular diseases, oncology, bone health, and developing MariTide obesity therapy.
Core Business Divisions & Flagship Offerings
Prolia & Xgeva Bone Therapeutics
Enbrel Immunology
Repatha Cholesterol
MariTide Obesity Trial
Explore All 100 Most Valued Companies
Compare market caps, sector distribution, and major shareholder networks.